Clinical Trial Update: Simvastatin Treatment of Patients With Acute Optic Neuritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating simvastatin for acute optic neuritis; the study status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Optic Neuritis

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Optic Neuritis, Multiple Sclerosis | Phase 3 | Status: UNKNOWN